A 52-year-old man from rural Maharashtra presents with a 6-month history of progressive dyspnea, persistent dry cough, and low-grade fever. Chest X-ray shows bilateral hilar lymphadenopathy with upper lobe infiltrates. Bronchoscopy with transbronchial biopsy reveals non-caseating granulomas. Serum calcium is 11.2 mg/dL (normal 8.5–10.5). ACE level is elevated. Which of the following best explains the pathologic mechanism underlying the granuloma formation in this condition?

Explanation

## Diagnosis: Sarcoidosis The clinical presentation (non-caseating granulomas, hilar lymphadenopathy, elevated ACE, hypercalcemia) is pathognomonic for sarcoidosis, a systemic granulomatous disease of unknown etiology. ## Pathologic Mechanism of Granuloma Formation **Key Point:** Chronic granulomatous inflammation in sarcoidosis is driven by **Type IV (cell-mediated) hypersensitivity**, not immune complexes or IgE. ### Cellular Sequence 1. **Antigen presentation** → Dendritic cells present unknown antigen (possibly organic or inorganic) to naive T cells 2. **Th1 and Th17 differentiation** → IL-2, IFN-γ (Th1) and IL-17 (Th17) production 3. **Macrophage activation** → IFN-γ and TNF-α activate macrophages to epithelioid cells 4. **Granuloma assembly** → Epithelioid macrophages fuse into multinucleated giant cells, surrounded by lymphocytes 5. **Sustained inflammation** → Chronic recruitment and activation perpetuates the granuloma **High-Yield:** Non-caseating granulomas are the hallmark; they differ from tuberculosis (caseating) because the antigen is poorly immunogenic or the immune response is insufficient for tissue necrosis. ### Why ACE and Hypercalcemia Occur - **ACE (angiotensin-converting enzyme)** is produced by epithelioid macrophages within granulomas → elevated serum levels - **Hypercalcemia** results from extrarenal 1α-hydroxylase activity in activated macrophages → increased calcitriol (active vitamin D) production **Clinical Pearl:** Elevated ACE and hypercalcemia are markers of granuloma burden and disease activity, not the primary pathogenic mechanism. ## Why This Is Type IV, Not Other Hypersensitivity Types | Feature | Type IV (Cell-Mediated) | Type II (Antibody) | Type III (Immune Complex) | Type I (IgE) | |---------|---|---|---|---| | **Mediator** | T cells, macrophages | IgG/IgM antibodies | Immune complexes | IgE, mast cells | | **Onset** | 24–72 hours | Minutes to hours | 3–8 hours | Minutes | | **Sarcoidosis fit** | ✓ (granuloma = T cell + macrophage) | ✗ (no antibodies to antigen) | ✗ (no vasculitis pattern) | ✗ (acute, not chronic) | **Mnemonic:** **GRIT** = **G**ranuloma = **R**eactive **I**mmunity **T**ype IV